Your session is about to expire
← Back to Search
Imaging Agent
Near Infrared Imaging for Lung Cancer
Phase 1
Waitlist Available
Led By Yolonda L. Colson, MD, PhD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Summary
This trial is testing if surgeons can find and remove the first lymph node that a tumor drains into. Doing this could help improve the ability to find and remove all tumor cells.
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To evaluate the safety and efficacy of near-infrared technology to guide therapeutic sentinel lymph node dissection in patients with lung cancer.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Near Infrared ImagingExperimental Treatment1 Intervention
The intervention to be administered is indocyanine green dye.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Near Infrared Imaging
2013
Completed Phase 1
~10
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,085 Previous Clinical Trials
341,723 Total Patients Enrolled
Brigham and Women's HospitalOTHER
1,628 Previous Clinical Trials
11,474,583 Total Patients Enrolled
Beth Israel Deaconess Medical CenterOTHER
840 Previous Clinical Trials
13,011,662 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant or breastfeeding.You have lung cancer that can be removed with surgery.You do not want to have further surgery.You are allergic to iodine or seafood.
Research Study Groups:
This trial has the following groups:- Group 1: Near Infrared Imaging
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger